FDA Delays Moderna Covid-19 Vaccine for Adolescents to Review Rare Myocarditis Side Effect - WSJ

FDA Delays Moderna Covid-19 Vaccine for Adolescents to Review Rare Myocarditis Side Effect - WSJ: Moderna asked the Food and Drug Administration in June to expand use of the company’s Covid-19 vaccine to 12-to-17-year-olds, but the agency has held off while it looks into the risk of myocarditis, a rare heart condition.